Steady-State Visually Evoked Potentials as Readouts for Abnormal GSK3β Activity in Drosophila
Authors:
- Oscar SolisOSOscar Solis
- Toby Shaw-McGrathTSToby Shaw-McGrath
- Alex R. WadeAlex R. Wade
- Ines HahnInes Hahn
Preprint
Abstract
Glycogen synthase kinase 3β (GSK3β) is important in neuronal development and maintenance, acting as a key regulator by controlling a broad range of cellular processes. The effects of its dysregulation range from impairments in axonal transport and energy metabolism to synapse formation and neuronal plasticity. However, how such cellular defects link to neuronal dysfunction is less well studied despite the links between GSK3β and various neurological conditions, such as Alzheimer’s and Parkinson’s diseases, mood disorders and autism. Here we used a steady-state visually evoked potential (SSVEP) assay with Drosophila to measure the effect of altering GSK3β expression on neuronal function. We recorded SSVEPs from flies that expressed constitutively active or inactive (kinase-dead) variants of GSK3β and showed that the visual responses of these flies differed from those of controls. This was indicated by increased response latency and reduced photoreceptor maximum response ( R max ). Importantly, multivariate pattern classification can distinguish between over- and inactive GSK3β conditions. Taken together, we show that SSVEPs provide a powerful tool for future studies to link the molecular and cellular functions of GSK3β with their effects on neuronal function. Furthermore, we introduce a monitoring protocol that ensures the quality of datasets to support future fly SSVEP experiments.Keywords
Funding Information
- Academy of Medical Science Springboard Award (SBF008\1140)
- Academy of Medical Science Springboard Award (BBSRC New Investigator Award)
- Academy of Medical Science Springboard Award (APP46392)
This publication has 52 references indexed in Scilit:
- Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future ProspectsEuropean Journal of Medicinal Chemistry, 2023
- New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseasesBiochemical Pharmacology, 2023
- Re‐evaluating the actin‐dependence of spectraplakin functions during axon growth and maintenanceDevelopmental Neurobiology, 2022
- Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseasesMedicinal Research Reviews, 2021
- Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromesMolecular Biology Reports, 2021
- Glycogen synthase kinase-3beta is associated with Parkinson's diseaseNeuroscience Letters, 2009
- GSK3 alpha and GSK3 beta are necessary for axon formationFEBS Letters, 2007
- Both the Establishment and the Maintenance of Neuronal Polarity Require Active MechanismsCell, 2005
- Targeted increase in shaggy activity levels blocks wingless signalingGenesis, 2002
- A new statistic for steady-state evoked potentialsElectroencephalography and Clinical Neurophysiology, 1991